The subject of follow-on biologics has been extensively discussed on iHub’s Biotech Values board for the past few years. Here are some references: <a href='read_msg.asp?message_id=17057467'>#msg-17057467</a> (Latest legislation) <a href='read_msg.asp?message_id=13425482'>#msg-13425482</a> (Overview of the issues) <a href='read_msg.asp?message_id=11358021'>#msg-11358021</a> (FDA approval of Omnitrope) <a href='read_msg.asp?message_id=5251149'>#msg-5251149</a> (This 2004 article is still a good read) Regards, Dew p.s. Welcome to the board!